(AQST) Aquestive Therapeutics - Performance 63.8% in 12m
AQST performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-22.45%
#86 in Peer-Group
Rel. Strength
88.82%
#859 in Stock-Universe
Total Return 12m
63.82%
#20 in Peer-Group
Total Return 5y
-4.28%
#77 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 5.66 USD |
| 52 Week Low | 2.22 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 93.40 |
| Buy/Sell Signal +-5 | 1.07 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: AQST (63.8%) vs XLV (-5.3%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-0.36% | 135% | 355% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
4.34% | 16.6% | 86.1% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-2.05% | -15.3% | 417% | 63.7 | 35.8 | 1.2 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.68% | 4.53% | 55.5% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-4.16% | 7.17% | 55.3% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-2.74% | -5.77% | 51.3% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-8.26% | -8.51% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
4.73% | 19.8% | 64.1% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: AQST vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AQST
| Total Return (including Dividends) | AQST | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 12.57% | 0.95% | 4.08% |
| 3 Months | 66.53% | 1.54% | 19.65% |
| 12 Months | 63.82% | -5.25% | 12.88% |
| 5 Years | -4.28% | 45.67% | 113.48% |
| Trend Score (consistency of price movement) | AQST | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 41.2% | 24.8% | 86.9% |
| 3 Months | 71.2% | -21.1% | 97.2% |
| 12 Months | -56.6% | -78.2% | 46% |
| 5 Years | -31% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th80.50 | 11.51% | 8.16% |
| 3 Month | %th82.50 | 64.00% | 39.18% |
| 12 Month | %th90.50 | 72.90% | 45.13% |
| 5 Years | %th59.00 | -34.29% | -55.16% |
FAQs
Does Aquestive Therapeutics (AQST) outperform the market?
Yes,
over the last 12 months AQST made 63.82%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.25%.
Over the last 3 months AQST made 66.53%, while XLV made 1.54%.
Performance Comparison AQST vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AQST vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.3% | 8.5% | 22.4% | 51% |
| US NASDAQ 100 | QQQ | 8.5% | 8.5% | 21% | 53% |
| German DAX 40 | DAX | 6.1% | 10.7% | 10.3% | 32% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.8% | 7.3% | 18.1% | 43% |
| Hongkong Hang Seng | HSI | 9.5% | 10.1% | 2.2% | 27% |
| India NIFTY 50 | INDA | 9.3% | 12.6% | 22.9% | 66% |
| Brasil Bovespa | EWZ | 13.8% | 10.7% | 6.4% | 61% |
AQST vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.6% | 10.4% | 18.9% | 41% |
| Consumer Discretionary | XLY | 8.3% | 10.1% | 30.1% | 47% |
| Consumer Staples | XLP | 9.6% | 12.7% | 23.3% | 56% |
| Energy | XLE | 6.4% | 7.4% | 28.9% | 61% |
| Financial | XLF | 9.2% | 9% | 18.7% | 36% |
| Health Care | XLV | 7.7% | 11.6% | 32.4% | 69% |
| Industrial | XLI | 7.5% | 7.7% | 15.4% | 38% |
| Materials | XLB | 7.3% | 8.3% | 19% | 57% |
| Real Estate | XLRE | 8.8% | 13.2% | 23% | 53% |
| Technology | XLK | 8.3% | 5.7% | 18.1% | 55% |
| Utilities | XLU | 7.4% | 9.8% | 20.1% | 41% |
| Aerospace & Defense | XAR | 7.9% | 6.1% | 4.3% | 15% |
| Biotech | XBI | 4.7% | 8.9% | 32% | 71% |
| Homebuilder | XHB | 5% | 4.2% | 26.8% | 58% |
| Retail | XRT | 8% | 9.8% | 27.9% | 53% |
AQST vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 8.1% | 7.28% | 37.4% | 70% |
| Natural Gas | UNG | 11.6% | 20.7% | 50.8% | 69% |
| Gold | GLD | 8.6% | 12.7% | 7.5% | 24% |
| Silver | SLV | 7.6% | 11% | 8.6% | 44% |
| Copper | CPER | -0.7% | -0.8% | 1.4% | 41% |
AQST vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 8.3% | 10.9% | 26.9% | 66% |
| iShares High Yield Corp. Bond | HYG | 8.6% | 11.3% | 25.8% | 54% |